← back to search

Louis Grandjean

Institute of Child Health · GB
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Diagnosis and treatment of tuberculosis, and COVID-19 Clinical Research Studies.
h-index
35
citations
6,231
works
149
NIH funding
primary concept
Medicine
email

Recent publications

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2026cited by 3position: contributordoi
Reducing mapping reference and lineage bias in <i>Mycobacterium tuberculosis</i>.
2026cited by 0position: contributordoi
Ciprofloxacin prophylaxis in allogeneic haematopoietic cell transplantation reduces bacteraemia but increases antimicrobial resistance without improving patient outcomes.
2026cited by 0position: contributordoi
A tiled amplicon protocol for culture-free whole-genome sequencing of <i>M. tuberculosis</i> from clinical specimens.
2026cited by 0position: contributordoi
The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis.
2026cited by 0position: contributordoi
A new method for detecting mixed Mycobacterium tuberculosis infection and reconstructing constituent strains provides insights into transmission
Genome Medicine 2025cited by 5position: middledoi
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
2025cited by 5position: contributordoi
A new method for detecting mixed Mycobacterium tuberculosis infection and reconstructing constituent strains provides insights into transmission.
2025cited by 3position: contributordoi
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2025cited by 2position: contributordoi
The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis
American Journal of Respiratory and Critical Care Medicine 2025cited by 1position: middledoi
Carbapenem-Resistant Infections in Neonates and Children in Latin America: A Literature Review.
2025cited by 1position: contributordoi
Case Report: Use of extracorporeal support to treat a fulminant <i>Mycobacterium bovis</i> infection and complex broncho-oesophageal fistula in a child.
2025cited by 0position: contributordoi
Dissecting rifampicin heteroresistance in <i>Mycobacterium tuberculosis</i>: integrating whole-genome sequencing with phenotypic and clonal validation.
2025cited by 0position: contributordoi
The Achilles' heel of the Trojan Horse? A systematic evaluation of cefiderocol susceptibility testing.
2025cited by 0position: contributordoi
Comparative evaluation of disc diffusion and broth microdilution methods for aztreonam/avibactam susceptibility testing in Enterobacterales.
2025cited by 0position: contributordoi
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach
Nature Communications 2024cited by 45position: middledoi
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies
The Lancet Respiratory Medicine 2024cited by 43position: middledoi
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach.
2024cited by 37position: contributordoi
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies.
2024cited by 28position: contributordoi
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
2024cited by 20position: contributordoi
Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis
Genome Medicine 2024cited by 16position: middledoi
Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis.
2024cited by 11position: contributordoi
Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients.
2024cited by 8position: contributordoi
Prevalence of non‐communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta‐analysis
Tropical Medicine & International Health 2024cited by 6position: middledoi
Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis.
2024cited by 5position: contributordoi
Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning.
2024cited by 5position: contributordoi
Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial.
2024cited by 5position: contributordoi
Antimicrobial resistance-attributable mortality: a patient-level analysis.
2024cited by 3position: contributordoi
Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing.
2024cited by 3position: contributordoi
A new method for detecting mixed <i>Mycobacterium tuberculosis</i> infection and reconstructing constituent strains provides insights into transmission
2024cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

David Moore · London School of Hygiene & Tropical Medicine18 papers (2012–2022)Robert H. Gilman · Johns Hopkins University16 papers (2012–2022)Philip W Fowler · Nuffield Orthopaedic Centre13 papers (2021–2024)Shaheed Vally Omar · National Institute for Communicable Diseases12 papers (2021–2024) · 11 papers (2012–2021)James A. Seddon · University of London10 papers (2017–2026)Zamin Iqbal · Bioinformatics Institute10 papers (2021–2024)François Balloux · University College London9 papers (2020–2024)Patricia Sheen · University of Cape Town8 papers (2012–2022) · 8 papers (2013–2022)Guy E Thwaites · Friedrich Schiller University Jena8 papers (2022–2026)Jason R. Andrews · Stanford University7 papers (2018–2023)Derrick W. Crook · Nuffield Orthopaedic Centre7 papers (2021–2022)Nguyen Thuy Thuong Thuong · Center for Systems Biology7 papers (2021–2024)A. Sarah Walker · The Royal Free Hospital7 papers (2021–2024) · 7 papers (2020–2026)Graeme Meintjes · Johns Hopkins Medicine7 papers (2021–2024)Matthias Merker · University Hospital Frankfurt6 papers (2021–2024)Stefan Niemann · University Hospital of Bern6 papers (2021–2024)David Goldblatt · Institute of Infection and Immunity6 papers (2020–2024)